Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine biomarkers which can predict response to ablation therapy in patients with Barretts esophagus.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mayo Clinic
Collaborators
NCT05745857 · Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, and more
NCT06523374 · Barrett's Esophagus, Esophageal Adenocarcinoma
NCT06071845 · Barrett Esophagus, Barretts Esophagus With Dysplasia, and more
NCT02198976 · Barrett's Esophagus
NCT00590239 · Barrett's Esophagus, Neoplasms, and more
Columbia University
New York, New York
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions